Revenue Recognition - Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Loss (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Profit (Loss) [Line Items]
Revenue	$ 4,107,494	$ 2,409,953
Cost of revenue	1,284,375	734,285
Gross profit	$ 2,823,119	1,675,668
Gross Profit %	68.73%
Assets	$ 3,821,429	2,879,103
Net income (loss)	(5,562,971)	$ (9,813,666)
Global Stem Cells Group [Member]
Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Profit (Loss) [Line Items]
Revenue	4,107,494
Cost of revenue	1,284,375
Gross profit	$ 2,823,119
Gross Profit %	68.73%
Assets	$ 1,951,853
Net income (loss)	303,730
Meso Numismatics [Member]
Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Profit (Loss) [Line Items]
Revenue
Cost of revenue
Gross profit
Gross Profit %	0.00%
Assets	$ 1,869,576
Net income (loss)	$ (5,866,701)